Global Industry Analysts, Inc., Oct 2006, Pages: 699
Antivirals, Hepatitis B
& C Antivirals, and Other Antivirals (includes
corresponding Graph/Chart) III-40
HIV/AIDS Prevalence in Europe III-41
HIV/AIDS Statistics in Western Europe III-41
UK Dominates
Global Industry Analysts, Inc., Jan 2011, Pages: 804
to Develop HepatitisC Vaccine
Novavax and Bharat Biotech Form Alliance to Develop Pandemic
Flu Vaccine
Panacea Biotech Joins Hands with NVI to Create Polio Vaccine
Immune Response Ties Up
Decision Resources, Inc., May 2010, Pages: 22
Although the market is already crowded, antiviral agents that can treat diseases such as HIV and hepatitisC virus (HCV) can still expect success. This potential for success is only one
Global Markets Direct, Nov 2011, Pages: 117
Patients For HEPLISAV Hepatitis B Vaccine
Nov 28, 2006: Dynavax's HEPLISAV Hepatitis B Vaccine Shows Statistically Significant Results In Phase III Trial
Sep 28, 2010: Dynavax Announces DSMB Clearance
Research In China, July 2007, Pages: 18
of market shares. The targeted markets are mainly focused on major diseases such as hepatitis B, hepatitisC, AIDS and syphilitic disease, etc.
Shanghai Kehua Bio-engineering Co., Ltd. started to enter the field
Research In China, July 2007, Pages: 18
of market shares. The targeted markets are mainly focused on major diseases such as hepatitis B, hepatitisC, AIDS and syphilitic disease, etc.
Shanghai Kehua Bio-engineering Co., Ltd. started to enter the field
Datamonitor, Dec 2010, Pages: 126
damage and cirrhosis
Hepatocellular cancer
Risk factors
Hepatitis infection
Hepatitis B
HepatitisC
Alcohol
Aflatoxin exposure
Genetic predisposition
Diagnosis and screening
Complexities of early
John Wiley and Sons Ltd, Dec 2010, Pages: 256
at the conference still have access to the proceedings. Contributors.
Preface.
Introduction Baveno I to Baveno V . . . and Beyond (Roberto de Franchis).
SYMPOSIUM 1 DIAGNOSTIC TOOLS.
Lecture 1 Hepatic Venous
TriMark Publications, Oct 2010, Pages: 243
target the human immunodeficiency virus (HIV, the virus that causes AIDS), the herpes virus (HSV-1 and HSV-2), bacterial infections and hepatitisC (HCV). A number of exciting novel anti-viral
TriMark Publications, Nov 2008, Pages: 310
.9: Recommendations for Diagnostic Testing for HepatitisC 60
Table 4.10: HepatitisCStatistics 60
Table 4.11: Gen-Probe Clinical Diagnostic Products Test for the Detection of HCV 62
Table 5.1: Biomarkers in Heart
John Wiley and Sons Ltd, Dec 2010, Pages: 800
. Edwards).
19 Racial and Ethnic Issues in Drug Regulation (Lionel D. Edwards, J-M. Husson, E. Labbe, C. Naito, M. Papaluca Amati, S. Walker, R.L., Williams, & H. Yasurhara).
20 Special Populations
Business Monitor International, Sep 2010, Pages: 73
people are thought to be infected by the Hepatitis B or C virus in Bangladesh. The data has also revealed that the number of patients contracting the Hepatitis B virus in the country has been increasing
Elsevier Science and Technology, Jan 2012, Pages: 672
and related amino acids. He has ten years of pharmaceutical industry experience and has contributed to FDA documents for the indications of multiple sclerosis, melanoma, head and neck cancer and hepatitisC
Business Monitor International, Aug 2010, Pages: 87
announced in July 2010 that it was planning to invest PKR4bn (US$46.4mn) in the production of pegylated interferon to treat hepatitisC over the next two years. The company stated that local production
